Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, CME Group Inc’s stock clocked out at $270.12, down -0.11% from its previous closing price of $270.42. In other words, the price has decreased by -$0.11 from its previous closing price. On the day, 1.18 million shares were traded. CME stock price reached its highest trading level at $273.34 during the session, while it also had its lowest trading level at $268.82.
Ratios:
To gain a deeper understanding of CME’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 37.81 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.85. For the most recent quarter (mrq), Quick Ratio is recorded 1.02 and its Current Ratio is at 1.02. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.13.
On September 25, 2025, Citigroup Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $300.
UBS Downgraded its Buy to Neutral on July 24, 2025, while the target price for the stock was maintained at $305.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 20 ’25 when Sammann Derek sold 7,200 shares for $275.67 per share. The transaction valued at 1,984,798 led to the insider holds 7,022 shares of the business.
Sammann Derek bought 7,200 shares of CME for $1,979,928 on Nov 20 ’25. On Nov 03 ’25, another insider, Ford Harold Eugene Jr., who serves as the Director of the company, sold 1,000 shares for $263.53 each. As a result, the insider received 263,530 and left with 1,091 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CME now has a Market Capitalization of 97405206528 and an Enterprise Value of 98712895488. As of this moment, CME’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.18, and their Forward P/E ratio for the next fiscal year is 23.23. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.62. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.23 while its Price-to-Book (P/B) ratio in mrq is 3.45. Its current Enterprise Value per Revenue stands at 15.46 whereas that against EBITDA is 21.965.
Stock Price History:
The Beta on a monthly basis for CME is 0.28, which has changed by 0.15416133 over the last 52 weeks, in comparison to a change of 0.12529528 over the same period for the S&P500. Over the past 52 weeks, CME has reached a high of $290.79, while it has fallen to a 52-week low of $224.62. The 50-Day Moving Average of the stock is -0.44%, while the 200-Day Moving Average is calculated to be -0.04%.
Shares Statistics:
It appears that CME traded 1.90M shares on average per day over the past three months and 1876750 shares per day over the past ten days. A total of 359.85M shares are outstanding, with a floating share count of 359.05M. Insiders hold about 0.43% of the company’s shares, while institutions hold 91.17% stake in the company. Shares short for CME as of 1763078400 were 5410273 with a Short Ratio of 2.84, compared to 1760486400 on 4493938. Therefore, it implies a Short% of Shares Outstanding of 5410273 and a Short% of Float of 1.5.
Dividends & Splits
With its trailing 12-month dividend rate of 4.9, CME has a forward annual dividend rate of 4.87. Against a Trailing Annual Dividend Yield of 0.018119961. The stock’s 5-year Average Dividend Yield is 3.47. The current Payout Ratio is 107.52% for CME, which recently paid a dividend on 2025-09-09 with an ex-dividend date of 2025-12-12. Stock splits for the company last occurred on 2012-07-23 when the company split stock in a 5:1 ratio.
Earnings Estimates
A comprehensive evaluation of CME Group Inc (CME) is underway, with the input of 12.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $2.9, with high estimates of $3.09 and low estimates of $2.71.
Analysts are recommending an EPS of between $11.29 and $10.98 for the fiscal current year, implying an average EPS of $11.16. EPS for the following year is $11.64, with 15.0 analysts recommending between $12.38 and $11.13.
Revenue Estimates
In. The current quarter, 7 analysts expect revenue to total $1.62B. It ranges from a high estimate of $1.68B to a low estimate of $1.53B. As of. The current estimate, CME Group Inc’s year-ago sales were $1.53BFor the next quarter, 7 analysts are estimating revenue of $1.66B. There is a high estimate of $1.7B for the next quarter, whereas the lowest estimate is $1.61B.
A total of 12 analysts have provided revenue estimates for CME’s current fiscal year. The highest revenue estimate was $6.62B, while the lowest revenue estimate was $6.4B, resulting in an average revenue estimate of $6.51B. In the same quarter a year ago, actual revenue was $6.13BBased on 12 analysts’ estimates, the company’s revenue will be $6.8B in the next fiscal year. The high estimate is $7.14B and the low estimate is $6.57B.
